🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Nuvation Bio Inc.

NUVB Healthcare
$6.22 +$0.12 (1.97%)
Market Cap: $2.18 B
Gurus Holding
6
Popularity Rank
#1445
% of Shares Held
2.77%
Net Activity (Q2 2026)
+$6.34 M

Guru Ownership Trend

Guru Analysis for Nuvation Bio Inc. (NUVB)

Nuvation Bio Inc. (NUVB), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q2 2026, a total of 6 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $60.52 M.

Top institutional holders include Stanley Druckenmiller and Cliff Asness.

Institutional sentiment is currently Bullish. This is evidenced by a $6.34 M net inflow during the quarter.

Recent activity highlights Renaissance Technologies (RenTech) who increased their stake by 140.7%.

Key Holders

Recent Activity Breakdown (Q2 2026)

+$7.55 M
Total Buy Value
New Buys 1
Additions 2
-$1.21 M
Total Sell Value
Reductions 0
Sold Out 2

Guru Consensus (Q2 2026)

Based on recent activity
Net Sellers
2
Net Buyers
3

FAQs for Nuvation Bio Inc. (NUVB)

Major holders include Stanley Druckenmiller ($25.79 M), Cliff Asness ($13.38 M), Renaissance Technologies (RenTech) ($7.65 M). According to the latest reported data, 6 tracked investment managers collectively hold approximately 9.73 M shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $6.34 M, with 3 managers increasing positions and 2 managers reducing holdings.

During the most recent reporting period, 0 managers trimmed their positions, while 2 fully exited NUVB. The total reported sell value was $1.21 M.

Yes, 1 managers opened new positions in NUVB, and 2 increased their existing holdings. The total reported buy value was $7.55 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.49% 4,539,800 $25.79 M Q2 2026
0.00% Add 18.1% 2,356,429 $13.38 M Q2 2026
0.01% Add 140.7% 1,345,995 $7.65 M Q2 2026
0.13% 1,270,504 $7.22 M Q2 2026
0.00% New Buy 182,152 $1.03 M Q2 2026
0.01% 34,995 $198,772 Q2 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form